
    
      The study was designed as randomized, controlled, clinical trial. patients who were
      undergoing chemoradiation were divided into two groups: Group I: was given conventional
      treatment. Group II: was given melatonin therapy in combination with the conventional
      treatment.

      All patients were clinically evaluated at the start the radiotherapy, three weeks and six
      weeks later for pain and oral mucositis severity. in addition, the total antioxidant capacity
      of the melatonin was evaluated at the start of the radiotherapy and six weeks later.
    
  